| Literature DB >> 25306394 |
Viola Bigatto1, Francesca De Bacco1, Elena Casanova1, Gigliola Reato2, Letizia Lanzetti2, Claudio Isella2, Ivana Sarotto1, Paolo M Comoglio3, Carla Boccaccio4.
Abstract
The inflammatory cytokine Tumor Necrosis Factor Alpha (TNF-α) is known to trigger invasive growth, a physiological property for tissue healing, turning into a hallmark of progression in cancer. However, the invasive response to TNF-α relies on poorly understood molecular mechanisms. We thus investigated whether it involves the MET oncogene, which regulates the invasive growth program by encoding the tyrosine kinase receptor for Hepatocyte Growth Factor (HGF). Here we show that the TNF-α pro-invasive activity requires MET function, as it is fully inhibited by MET-specific inhibitors (small-molecules, antibodies, and siRNAs). Mechanistically, we show that TNF-α induces MET transcription via NF-κB, and exploits MET to sustain MEK/ERK activation and Snail accumulation, leading to E-cadherin downregulation. We then show that TNF-α not only induces MET expression in cancer cells, but also HGF secretion by fibroblasts. Consistently, we found that, in human colorectal cancer tissues, high levels of TNF-α correlates with increased expression of both MET and HGF. These findings suggest that TNF-α fosters a HGF/MET pro-invasive paracrine loop in tumors. Targeting this ligand/receptor pair would contribute to prevent cancer progression associated with inflammation.Entities:
Keywords: HGF; Inflammation; Invasion; MET; MET inhibitor; TNF-α
Mesh:
Substances:
Year: 2014 PMID: 25306394 PMCID: PMC5528655 DOI: 10.1016/j.molonc.2014.09.002
Source DB: PubMed Journal: Mol Oncol ISSN: 1574-7891 Impact factor: 6.603